+62.2%
GSK vs UPST
-13.8%
+76.0%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | UPST | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -1.6% | -0.3% | -1.9% |
| 7D | -1.8% | -3.5% | +1.7% | -1.8% |
| 30D | -2.2% | -7.1% | +4.9% | -2.1% |
| 3M | -1.8% | -13.1% | +11.3% | -1.7% |
| 6M | -10.6% | -1.1% | -9.5% | -10.6% |
| YTD | +4.4% | -35.9% | +40.3% | +4.6% |
| 1Y | +30.4% | -57.4% | +87.8% | +30.9% |
| All | +62.2% | -13.8% | +76.0% | +56.3% |
Cumulative growth
Daily Returns
Daily percentage return beside UPST.
Daily Out/Under-Performance
Portfolio return minus UPST return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UPST return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded UPST wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling